Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Intercure Ltd. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −6 vs. Q3 2022
- Shares held
- 2.95M
- −1.90M (−39.2%) vs. Q3 2022
- Total value
- $9.75M
- −$12.1M (−55.4%) vs. Q3 2022
- New holders
- 1
- 9 more added
- Sold out
- 7
- 1 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $764.1K |
| Q1 2026 | 15 | $617.9K |
| Q4 2025 | 18 | $796.3K |
| Q3 2025 | 22 | $3.44M |
| Q2 2025 | 19 | $3.68M |
| Q1 2025 | 15 | $3.50M |
| Q4 2024 | 17 | $4.00M |
| Q3 2024 | 20 | $5.22M |
| Q2 2024 | 19 | $6.04M |
| Q1 2024 | 17 | $8.92M |
| Q4 2023 | 18 | $4.93M |
| Q3 2023 | 20 | $5.43M |
| Q2 2023 | 19 | $5.30M |
| Q1 2023 | 18 | $8.29M |
| Q4 2022 | 15 | $9.75M |
| Q3 2022 | 21 | $21.9M |
| Q2 2022 | 18 | $38.1M |
| Q1 2022 | 19 | $34.8M |
| Q4 2021 | 23 | $26.9M |
| Q3 2021 | 16 | $16.3M |
| Q2 2021 | 2 | $5.37M |
| Q1 2021 | 1 | $8.38M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Intercure Ltd.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 317 | $1.00K | 0.00% | +225+244.6% | Added |
| Toronto Dominion Bank | 198 | $1.00K | 0.00% | +198 | New |
| Advisor Group Holdings, Inc. | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,966 | $6.49K | 0.00% | −4,371−69.0% | Reduced |
| Bank of America Corp | 2,247 | $7.42K | 0.00% | +1,681+297.0% | Added |
| JPMorgan Chase & Co | 3,461 | $11.0K | 0.00% | +3,390+4,774.6% | Added |
| Morgan Stanley | 4,600 | $15.2K | 0.00% | 00.0% | Unchanged |
| Davy Global Fund Management Ltd | 12,336 | $40.7K | 0.01% | +613+5.2% | Added |
| Geode Capital Management, LLC | 14,148 | $46.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 24,162 | $79.7K | 0.00% | +11,203+86.4% | Added |
| Citadel Advisors LLC | 34,876 | $115.1K | 0.00% | +7,792+28.8% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 212,500 | $728.9K | 0.00% | 00.0% | Unchanged |
| AdvisorShares Investments LLC | 243,190 | $802.5K | 0.23% | +20,000+9.0% | Added |
| Mirae Asset Global Investments Co., Ltd. | 489,492 | $1.62M | 0.00% | +54,368+12.5% | Added |
| Ibex Investors LLC | 1,902,774 | $6.28M | 9.49% | +16,500+0.9% | Added |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −1,851,339−100.0% | Sold out |
| Cambria Investment Management, L.P. | 0 | $0 | 0.00% | −62,966−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −51,576−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −48,089−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −744−100.0% | Sold out |
| Sugarloaf Wealth Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −36−100.0% | Sold out |